NCT00523614View on ClinicalTrials.gov

Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous Thromboembolism

CompletedOBSERVATIONAL
Enrollment

3,400

Participants

Timeline

Start Date

July 31, 2007

Study Completion Date

June 30, 2008

Conditions
Venous Thromboembolism
Trial Locations (1)

10115

Center for Epidemilogy and Health Research, Berlin

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Center for Epidemiology and Health Research, Germany

OTHER